GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

sipavibart   Click here for help

GtoPdb Ligand ID: 13905

Synonyms: AZD-3152 | AZD3152 | Kavigale®
Approved drug
sipavibart is an approved drug
Compound class: Antibody
Comment: Sipavibart (AZD3152) is an anti-SARS-CoV-2 monoclonal antibody that targets the virus' surface spike (S) protein [1,5]. This agent was designed as pre-exposure prophylaxis of COVID-19 in immunocompromised patients [4].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EU EMA (2025)
International Nonproprietary Names Click here for help
INN number INN
12778 sipavibart
Synonyms Click here for help
AZD-3152 | AZD3152 | Kavigale®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1510
Other databases
GtoPdb PubChem SID 513757590
Search PubMed clinical trials sipavibart
Search PubMed titles sipavibart
Search PubMed titles/abstracts sipavibart